Produktbild
Walter Moos

Managing the Drug Discovery Process

How to Make It More Efficient and Cost-Effective

Ebook (EPUB Format)

Managing the Drug Discovery Process: How to Make It More Efficient and Cost-Effective thoroughly examines the current state of pharmaceutical research and development by providing chemistry-based perspectives on biomedical research, drug hunting and innovation. The book also considers the interplay of stakeholders, consumers, and the drug firm with attendant factors, including those that are technical, legal, economic, demographic, political, social, ecological, and infrastructural. Since drug research can be a high-risk, high-payoff industry, it is important to researchers to effectively and strategically manage the drug discovery process. T… Mehr

CHF 190.90

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen
Versandkostenfrei

Produktdetails


Weitere Autoren: Miller, Susan / Munk, Stephen / Munk, Barbara
  • ISBN: 978-0-08-100632-0
  • EAN: 9780081006320
  • Produktnummer: 35986278
  • Verlag: Elsevier Science & Techn.
  • Sprache: Englisch
  • Erscheinungsjahr: 2016
  • Seitenangabe: 536 S.
  • Plattform: EPUB

Über den Autor


Dr. Walter H. Moos retired as President of SRI Biosciences in early 2016 after more than a decade at the independent nonprofit SRI International (Stanford Research Institute), which he joined in 2005 as Vice President and Biosciences Division Head. He also managed corporate Information Technology Services at SRI from 2011-2014. Moos and his teams have made significant contributions to all phases of R&D, from early stage research on therapeutics and diagnostics to marketed pharmaceutical products. Prior to SRI he was Chairman and Chief Executive Officer of MitoKor (Migenix) and a Vice President at Chiron (Novartis) and Warner-Lambert/Parke-Davis (Pfizer). His teams have advanced many drugs and biologics from bench to bedside, supported by Alta Partners, the Gates Foundation, NIH, Pfizer, and others. He has served on about 20 business and scientific boards, not-for-profit and for-profit, including the Biotechnology Industry Organization (BIO), the Critical Path Institute, Keystone Symposia, Oncologic (Aduro), Onyx (Amgen), and Rigel. He has advised and served as a committee member for academic, government, and investor groups, including the University of Michigan, the National Academy of Sciences, and Red Abbey Venture Partners. He has founded several scientific journals, authored or edited 6 books, and has over 160 patents and publications. Moos has held faculty positions at major universities and has been an adjunct Professor at the University of California San Francisco since 1992. He holds Ph.D. and A.B. degrees in chemistry from the University of California Berkeley and Harvard University, respectively.

2 weitere Werke von Walter Moos:


Bewertungen


0 von 0 Bewertungen

Geben Sie eine Bewertung ab!

Teilen Sie Ihre Erfahrungen mit dem Produkt mit anderen Kunden.